EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 12 filers reported holding EVOKE PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $891,000 | +34.6% | 130,000 | 0.0% | 0.60% | +44.1% |
| Q1 2016 | $662,000 | +54.3% | 130,000 | 0.0% | 0.41% | +130.7% |
| Q4 2015 | $429,000 | -43.3% | 130,000 | -50.0% | 0.18% | -52.0% |
| Q3 2015 | $757,000 | -44.1% | 260,000 | +0.3% | 0.37% | -30.8% |
| Q2 2015 | $1,355,000 | -21.5% | 259,100 | +5.8% | 0.54% | -32.8% |
| Q1 2015 | $1,727,000 | +22.0% | 245,000 | +2.1% | 0.80% | +12.0% |
| Q4 2014 | $1,416,000 | -99.9% | 240,000 | -10.1% | 0.72% | -37.5% |
| Q3 2014 | $1,468,367,000 | +74740.3% | 267,000 | +10.1% | 1.14% | -32.3% |
| Q2 2014 | $1,962,000 | +0.3% | 242,500 | +3.9% | 1.69% | +17.1% |
| Q1 2014 | $1,956,000 | – | 233,400 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,433,113 | $2,623,000 | 0.55% |
| Worth Venture Partners, LLC | 336,516 | $616,000 | 0.30% |
| Wambolt & Associates, LLC | 32,000 | $59,000 | 0.03% |
| Pure Financial Advisors, LLC | 17,647 | $32,000 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,540 | $6,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 179 | $0 | 0.00% |
| NORTHERN TRUST CORP | 42,121 | $77,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 16,101 | $29,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 159,979 | $292,000 | 0.00% |